This is a very positive Update from $ISOLF
ISODIOL INTERNATIONAL INC. PROVIDES INVESTOR UPDATE
The Canadian Securities Exchange will continue to welcome companies with links to the U.S. cannabis market, such as Isodiol International Inc., a contrast to the statement made by the TMX on Oct. 17.
Marcos Agramont, chief executive officer of Isodiol International, stated: "Our shareholders are extremely important to us, and this clarification helps alleviate any uncertainties over listings in the cannabis sector. Richard Carleton, CEO [chief executive officer] of the CNSX Markets, has publicly stated he is willing to work with and support companies in this space (1)."
The company continues to differentiate itself from other companies in the cannabis sector by developing pharmaceutical technologies that allow it to expand its global footprint and operate under legal frameworks of local governing bodies.
(1) "Marijuana stocks fall as uncertainty over listings grips the sector," The Globe and Mail, Oct. 17, 2017.
About Isodiol International Inc.
Isodiol International is the market leader in pharmaceutical- and nutraceutical-grade phytochemical compounds and the industry leader in the manufacturing and development of phytoceutical consumer products.
Isodiol is the pioneer of many firsts for the cannabis industry, including commercialization of more than 99 per cent pure, bioactive pharmaceutical-grade cannabinoids, microencapsulations and nanotechnology for the highest-quality consumable and topical skin care products.
Isodiol's growth strategy includes the development of over-the-counter and pharmaceutical drugs, expanding its phytoceutical portfolio, and will aggressively continue international expansion into Latin America, Asia and Europe.
We seek Safe Harbor.
